BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32346746)

  • 21. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
    Polubothu S; McGuire N; Al-Olabi L; Baird W; Bulstrode N; Chalker J; Josifova D; Lomas D; O'Hara J; Ong J; Rampling D; Stadnik P; Thomas A; Wedgeworth E; Sebire NJ; Kinsler VA
    Br J Dermatol; 2020 Feb; 182(2):434-443. PubMed ID: 31111470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
    Pellegrini C; Maturo MG; Martorelli C; Suppa M; Antonini A; Kostaki D; Verna L; Landi MT; Peris K; Fargnoli MC
    Melanoma Res; 2017 Jun; 27(3):258-267. PubMed ID: 28146043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations.
    Williams EA; Montesion M; Shah N; Sharaf R; Pavlick DC; Sokol ES; Alexander B; Venstrom J; Elvin JA; Ross JS; Williams KJ; Tse JY; Mochel MC
    Mod Pathol; 2020 Dec; 33(12):2397-2406. PubMed ID: 32483240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
    Itin PH; Fistarol SK
    Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
    Urso C
    Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The sun and malignant melanoma].
    Garbe C
    Hautarzt; 1992 May; 43(5):251-7. PubMed ID: 1612913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma Risk and Melanocyte Biology.
    Bertrand JU; Steingrimsson E; Jouenne F; Bressac-de Paillerets B; Larue L
    Acta Derm Venereol; 2020 Jun; 100(11):adv00139. PubMed ID: 32346747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
    Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
    Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM
    J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Skin cancer risk factors in childhood: findings of a survey conducted within Italian areas with a different incidence of melanoma].
    Ramazzotti V; Cercato MC; Terrenato I; Santi P; Falcini F; Assennato G; Gattei E; Catricalà C; Natali PG
    Epidemiol Prev; 2011; 35(2):82-8. PubMed ID: 21628750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.
    Si L; Kong Y; Xu X; Flaherty KT; Sheng X; Cui C; Chi Z; Li S; Mao L; Guo J
    Eur J Cancer; 2012 Jan; 48(1):94-100. PubMed ID: 21788131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
    Burke LS; Hyland PL; Pfeiffer RM; Prescott J; Wheeler W; Mirabello L; Savage SA; Burdette L; Yeager M; Chanock S; De Vivo I; Tucker MA; Goldstein AM; Yang XR
    PLoS One; 2013; 8(8):e71121. PubMed ID: 23990928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for skin melanoma: genetic factors probably more important than exposure to sunlight].
    Pavel S; Smit NP
    Ned Tijdschr Geneeskd; 2004 Nov; 148(46):2267-72. PubMed ID: 15584541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic predisposition in cutaneous melanoma].
    Avilés JA; Lázaro P
    Actas Dermosifiliogr; 2006 May; 97(4):229-40. PubMed ID: 16801015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
    Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology and genetics of acquired and congenital melanocytic naevi.
    Maher NG; Scolyer RA; Colebatch AJ
    Pathology; 2023 Mar; 55(2):169-177. PubMed ID: 36635156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants.
    Hocker T; Tsao H
    Hum Mutat; 2007 Jun; 28(6):578-88. PubMed ID: 17295241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.